Get started
Author

Panagiotis Soldatos

Observed names: Soldatos, Panagiotis, Σολδάτος, Παναγιώτης
OpenAlex ID: A5031089165
Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real‐world data from a Greek registry
2023 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · European Journal of Neurology · 25
PDF
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
2023 · Michail Vikelis, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 17
PDF
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints
2024 · Michail Vikelis, Dimitrios Rikos, et al. · Expert Review of Neurotherapeutics · 14
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis
2020 · Michail Vikelis, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 13
PDF
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
2023 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 11
PDF
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine
2024 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Toxins · 10
PDF
Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study
2024 · Emmanouil V. Dermitzakis, Dimitrios Rikos, et al. · Brain Sciences · 7
PDF
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine
2024 · Emmanouil V. Dermitzakis, Michail Vikelis, et al. · Journal of Clinical Medicine · 7
PDF
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options
2024 · Emmanouil V. Dermitzakis, Andreas A. Argyriou, et al. · Journal of Clinical Medicine · 6
Eptinezumab to prevent difficult-to-treat migraine: prospective, six-month, real-world multicenter evidence from the GRASP study group
2026 · Emmanouil V. Dermitzakis, Andreas A. Argyriou, et al. · The Journal of Headache and Pain · 4
Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group
2025 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 4
PDF
Effects of Pausing and Re‐Initiating Fremanezumab After Continuous 24‐Month Treatment for Preventing Difficult‐To‐Treat Migraine: Prospective, Multicenter, Real‐World Data From the GRASP Study Group
2025 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · European Journal of Neurology · 4
PDF
OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group
2025 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Toxins · 3
PDF
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review
2024 · Dimitrios Rikos, Michail Vikelis, et al. · Journal of Clinical Medicine · 3
PDF
Real world, open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 (Vivinor®) for episodic migraine prophylaxis
2020 · Michail Vikelis, Emmanouil V. Dermitzakis, et al. · 3
PDF
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry
2024 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Expert Review of Neurotherapeutics · 2
Achieving International Headache Society-aspired optimal migraine control in fremanezumab-treated patients: A post-hoc analysis of a real-world, prospective study from the GRASP study group
2026 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Cephalalgia · 1
Efficacy of single-dose galcanezumab 240 mg on episodic or refractory chronic cluster headache: prospective, 4-week, real-world evidence from the GRASP study group
2026 · Michail Vikelis, Andreas A. Argyriou, et al. · Frontiers in Neurology · 1
PDF
Effectiveness of eptinezumab 300 mg dose escalation in partial responders to 100 mg among patients with difficult-to-treat migraine: A prospective, real-world study by the GRASP study group
2026 · Emmanouil V. Dermitzakis, Andreas A. Argyriou, et al. · Cephalalgia
Effectiveness and safety of sumatriptan 85 mg/naproxen sodium 500 mg combination for acute migraine: prospective real-world evidence from the GRASP Study Group
2026 · Dimitrios Rikos, Andreas A. Argyriou, et al. · Frontiers in Neurology
PDF
Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group
2026 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Toxins
Consensus Article: Updated Opinion of the Headache Scientific Panel of the Hellenic Neurological Society on the Use of Monoclonal Antibodies and Small Molecules Targeting the Cgrp Pathway in the Preventive Treatment of Episodic or Chronic Migraine and Clu
2026 · Βικελής, Μιχαήλ, Ρίκος, Δημήτριος, et al. · ΑΡΧΕΙΑ ΚΛΙΝΙΚΗΣ ΝΕΥΡΟΛΟΓΙΑΣ
PDF
Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group
2026 · Michail Vikelis, Dimitrios Rikos, et al. · Neurology International
PDF
Η λογική και το συναίσθημα: μοντελοποίηση της κίνησης στο χορό και τα όρια της αναγωγής
2026 · Soldatos, Panagiotis · DSpace - NTUA (National Technical University of Athens)
Re-assessing the clinical significance of long-term neuromuscular alterations following Onabotulinumtoxin-A (BoNTA) in chronic migraine: Letter to the editor on behalf of the GRASP study group
2026 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Clinical Neurophysiology Practice
PDF
Works count: 28
Citation count: 135
H-index: 7
I10-index: 6
Year
Topic
Type